HARROW HEALTH ($HROW) posted quarterly earnings results for Q1 2026 on Monday, May 11th. The company reported earnings of -$0.63 per share, missing estimates of -$0.41 by $0.22. The company also reported revenue of $44,200,000, missing estimates of $53,468,787 by $-9,268,787.
Stock price change since market close: -7.99%
You can see Quiver Quantitative's $HROW stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HARROW HEALTH Insider Trading Activity
HARROW HEALTH insiders have traded $HROW stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $HROW stock by insiders over the last 6 months:
- MANAGEMENT INC. OPALEYE has made 0 purchases and 5 sales selling 218,572 shares for an estimated $8,913,339.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
HARROW HEALTH Hedge Fund Activity
We have seen 104 institutional investors add shares of HARROW HEALTH stock to their portfolio, and 104 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LUXOR CAPITAL GROUP, LP added 610,204 shares (+198.5%) to their portfolio in Q4 2025, for an estimated $29,899,996
- MARSHALL WACE, LLP removed 307,809 shares (-60.6%) from their portfolio in Q4 2025, for an estimated $15,082,641
- DIMENSIONAL FUND ADVISORS LP added 208,972 shares (+56.4%) to their portfolio in Q1 2026, for an estimated $7,368,352
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 199,526 shares (-44.4%) from their portfolio in Q4 2025, for an estimated $9,776,774
- IKARIAN CAPITAL, LLC added 183,347 shares (+inf%) to their portfolio in Q4 2025, for an estimated $8,984,003
- FIRST TURN MANAGEMENT, LLC removed 160,234 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $7,851,466
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 159,538 shares (-73.9%) from their portfolio in Q4 2025, for an estimated $7,817,362
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
HARROW HEALTH Price Targets
Multiple analysts have issued price targets for $HROW recently. We have seen 4 analysts offer price targets for $HROW in the last 6 months, with a median target of $67.5.
Here are some recent targets:
- Thomas Shrader from BTIG set a target price of $63.0 on 04/17/2026
- Mayank Mamtani from B. Riley Securities set a target price of $65.0 on 04/07/2026
- Yi Chen from HC Wainwright & Co. set a target price of $70.0 on 03/19/2026
- Steve Seedhouse from Cantor Fitzgerald set a target price of $91.0 on 03/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
